Ligufalimab - CAS 2428381-55-7

Ligufalimab (AK 117) is a humanized IgG4 monoclonal antibody that targets CD47 without inducing red blood cell hemagglutination. Ligufalimab enhances phagocytosis and demonstrates significant antitumor activity. Due to its safety and activity profile, Ligufalimab is considered a promising therapeutic antibody candidate in oncology research.

Interleukin, Others

Others, Immunology/Inflammation

2428319

0.979

-20°C

Ice Packs

Inhibitory Antibodies